These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25304893)

  • 61. Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents.
    Küçükgüzel ŞG; Coşkun İ; Aydın S; Aktay G; Gürsoy Ş; Çevik Ö; Özakpınar ÖB; Özsavcı D; Şener A; Kaushik-Basu N; Basu A; Talele TT
    Molecules; 2013 Mar; 18(3):3595-614. PubMed ID: 23519201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues.
    Burguete A; Pontiki E; Hadjipavlou-Litina D; Villar R; Vicente E; Solano B; Ancizu S; Pérez-Silanes S; Aldana I; Monge A
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6439-43. PubMed ID: 17942306
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design and Synthesis of Novel Pyrazole-Substituted Different Nitrogenous Heterocyclic Ring Systems as Potential Anti-Inflammatory Agents.
    Nossier ES; Fahmy HH; Khalifa NM; El-Eraky WI; Baset MA
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338602
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
    Yewale SB; Ganorkar SB; Baheti KG; Shelke RU
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6616-20. PubMed ID: 23036953
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
    Brock SC; Tonussi CR
    Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anticancer and Anti-Inflammatory Activities of Some New Pyrazolo[3,4-
    El-Kashef H; El-Emary T; Verhaeghe P; Vanelle P; Samy M
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30332801
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II.
    El-Feky SA; Abd El-Samii ZK; Osman NA; Lashine J; Kamel MA; Thabet HKh
    Bioorg Chem; 2015 Feb; 58():104-16. PubMed ID: 25590381
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and biological activity of some novel pyrazolines.
    Venkataraman S; Jain S; Shah K; Upmanyu N
    Acta Pol Pharm; 2010; 67(4):361-6. PubMed ID: 20635531
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
    Azam MA; Dharanya L; Mehta CC; Sachdeva S
    Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and pharmacological investigation of 5-substituted-3-methylsulfanyl-1H-pyrazole-4-carboxylic acid ethyl esters as new analgesic and anti-inflammatory agents.
    Gokulan PD; Jayakar B; Alagarsamy V; Raja Solomon V
    Arzneimittelforschung; 2012 Oct; 62(10):457-62. PubMed ID: 22933047
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents.
    Bano S; Javed K; Ahmad S; Rathish IG; Singh S; Alam MS
    Eur J Med Chem; 2011 Dec; 46(12):5763-8. PubMed ID: 22019186
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design, synthesis, characterization and anti-inflammatory evaluation of novel pyrazole amalgamated flavones.
    Chavan HV; Bandgar BP; Adsul LK; Dhakane VD; Bhale PS; Thakare VN; Masand V
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1315-21. PubMed ID: 23357629
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antitumor evaluation and molecular docking study of substituted 2-benzylidenebutane-1,3-dione, 2-hydrazonobutane-1,3-dione and trifluoromethyl-1H-pyrazole analogues.
    Al-Suwaidan IA; Abdel-Aziz NI; El-Azab AS; El-Sayed MA; Alanazi AM; El-Ashmawy MB; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2015; 30(4):679-87. PubMed ID: 25472776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
    Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and biological evaluation of a novel series of pyrazolylcoumarins as anti-inflammatory and antioxidant agents.
    Aragade P; Venkatnarayanan R; Patil P
    Drug Res (Stuttg); 2013 Jan; 63(1):28-33. PubMed ID: 23447045
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and molecular modeling studies of anti-inflammatory active 1H-pyrrolizine-5-carboxamides.
    Barsoum FF
    Arch Pharm (Weinheim); 2011 Jan; 344(1):56-65. PubMed ID: 21213352
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis of nitro esters of prednisolone, new compounds combining pharmacological properties of both glucocorticoids and nitric oxide.
    Baraldi PG; Romagnoli R; Del Carmen Nuñez M; Perretti M; Paul-Clark MJ; Ferrario M; Govoni M; Benedini F; Ongini E
    J Med Chem; 2004 Jan; 47(3):711-9. PubMed ID: 14736251
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pyrazolobenzotriazinone derivatives as COX inhibitors: synthesis, biological activity, and molecular-modeling studies.
    Raffa D; Migliara O; Maggio B; Plescia F; Cascioferro S; Cusimano MG; Tringali G; Cannizzaro C; Plescia F
    Arch Pharm (Weinheim); 2010 Nov; 343(11-12):631-8. PubMed ID: 21110338
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rofecoxib analogues possessing a nitric oxide donor sulfohydroxamic acid (SO2NHOH) cyclooxygenase-2 pharmacophore: synthesis, molecular modeling, and biological evaluation as anti-inflammatory agents.
    Bhardwaj A; Huang Z; Kaur J; Knaus EE
    ChemMedChem; 2012 Jan; 7(1):62-7. PubMed ID: 21990143
    [No Abstract]   [Full Text] [Related]  

  • 80. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.